<\/p>\n
\u00a0D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), Kovid-19 a\u015f\u0131lama \u00f6nerilerini, salg\u0131n\u0131n yeni bir a\u015famas\u0131 i\u00e7in revize ederken sa\u011fl\u0131kl\u0131 \u00e7ocuklar ve ergenlerin mutlaka bir a\u015f\u0131ya ihtiya\u00e7 duymayabilece\u011fi ancak ya\u015fl\u0131 ve risk alt\u0131ndaki grubun son a\u015f\u0131s\u0131ndan 6 ila 12 ay sonra hat\u0131rlatma dozunu alabilece\u011fi belirtildi. <\/p>\n
DS\u00d6’den yap\u0131lan yaz\u0131l\u0131 a\u00e7\u0131klamaya g\u00f6re, \u00d6rg\u00fct’\u00fcn ba\u011f\u0131\u015f\u0131klama uzmanlar\u0131ndan olu\u015fan Stratejik Dan\u0131\u015fma Grubu’nun (SAGE), Omicron’un etkisini ve enfeksiyon ile a\u015f\u0131lama nedeniyle n\u00fcfus d\u00fczeyindeki y\u00fcksek ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 yans\u0131tmak i\u00e7in Kovid-19 a\u015f\u0131lar\u0131n\u0131n kullan\u0131m\u0131na \u00f6ncelik verilmesine y\u00f6nelik yol haritas\u0131n\u0131 revize etti.<\/p>\n
Yol haritas\u0131na g\u00f6re SAGE, SARS-CoV-2 enfeksiyonundan \u00f6l\u00fcm ve ciddi hastal\u0131k riski en y\u00fcksek olan ki\u015fileri korumaya \u00f6ncelik vermeye ve diren\u00e7li sa\u011fl\u0131k sistemlerini devam ettirmeye odaklanmay\u0131 s\u00fcrd\u00fcrd\u00fc.<\/p>\n
A\u015f\u0131lamada hat\u0131rlatma dozlar\u0131 ve bunlar\u0131n aral\u0131klar\u0131 hakk\u0131nda g\u00f6zden ge\u00e7irilmi\u015f tavsiyeler yer al\u0131rken Kovid-19 a\u015f\u0131lamas\u0131 i\u00e7in y\u00fcksek, orta ve d\u00fc\u015f\u00fck olmak \u00fczere \u00fc\u00e7 \u00f6ncelikli gruba de\u011finildi.<\/p>\n
Y\u00fcksek \u00f6ncelikli grup, ya\u015fl\u0131 yeti\u015fkinleri i\u00e7erirken orta \u00f6ncelikli grupta ayr\u0131ca bir hastal\u0131\u011f\u0131 olmayan sa\u011fl\u0131kl\u0131 yeti\u015fkinler (50-60 ya\u015f alt\u0131), d\u00fc\u015f\u00fck \u00f6ncelikli grupta ise 6-17 ya\u015f aras\u0131ndaki sa\u011fl\u0131kl\u0131 \u00e7ocuklar ve ergenler yer ald\u0131.<\/p>\n
Yayg\u0131n enfeksiyon ve a\u015f\u0131lama nedeniyle d\u00fcnya \u00e7ap\u0131nda y\u00fcksek d\u00fczeyde n\u00fcfus ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, a\u015f\u0131lamadaki esas ama\u00e7 ciddi hastal\u0131k ve \u00f6l\u00fcm tehdidiyle kar\u015f\u0131 kar\u015f\u0131ya olanlar\u0131n a\u015f\u0131lanmas\u0131na odaklamak oldu.<\/p>\n
Y\u00fcksek \u00f6ncelikli pop\u00fclasyon grubundaki ya\u015fl\u0131 yeti\u015fkinler ve di\u011fer \u00f6nemli risk fakt\u00f6rlerine sahip gen\u00e7ler i\u00e7in son a\u015f\u0131dan 6 veya 12 ay sonra ek hat\u0131rlatma dozu \u00f6nerildi.<\/p>\n
Ortak \u00f6ncelikli grup i\u00e7in de a\u015f\u0131lama ve hat\u0131rlatma dozlar\u0131 tavsiye ediliyor.<\/p>\n
D\u00fc\u015f\u00fck \u00f6ncelikli gruptaki sa\u011fl\u0131kl\u0131 \u00e7ocuk ve ergenlerin ise mutlaka a\u015f\u0131lanmas\u0131n\u0131 \u00f6nerilmezken bu grup i\u00e7in \u00fclkelerin hastal\u0131k y\u00fck\u00fc ve maliyet gibi fakt\u00f6rlere dayal\u0131 a\u015f\u0131lamay\u0131 d\u00fc\u015f\u00fcnmesi gerekti\u011fini belirtildi.<\/p>\n
Kovid-19 a\u015f\u0131lar\u0131n\u0131n ve ilave dozlar\u0131n her ya\u015f i\u00e7in g\u00fcvenli oldu\u011fu da belirtildi.<\/p>\n
SAGE Ba\u015fkan\u0131 Hanna Nohynek, “Yeni yol haritas\u0131n\u0131n \u00e7o\u011funlukla ya\u015fl\u0131 yeti\u015fkinler ve ciddi hastal\u0131k riski alt\u0131nda olanlar\u0131n a\u015f\u0131lanmas\u0131n\u0131n \u00f6nemini yeniden vurguluyor.” ifadesini kulland\u0131.<\/p>\n